Prospective Study of Hypofractionated Stereotactic Radiation Therapy (HFRT) With Erlotinib for Brain Metastases From NSCL: An Interim Report

Authors :: H.L. Hu
Y.F. Bai
M. Zeng
Source :: International Journal of Radiation Oncology*Biology*Physics. 96:E120
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Cancer Research
Radiation
business.industry
medicine.medical_treatment
Stereotactic radiation therapy
Oncology
medicine
Radiology, Nuclear Medicine and imaging
Erlotinib
business
Nuclear medicine
Prospective cohort study
Interim report
medicine.drug

Full Text Access

Tools